Why B-Cell Cancer Treatments Take So Long to Test
B-cell cancers are different. They develop slowly, which makes testing new treatments challenging. Researchers often use substitutes, known as surrogate endpoints, to speed up trials. But these shortcuts must be reliable for each type of disease and therapy. Let's explore how scientists ensure these